Vereta L A, Elisova T D, Voronkova G M
Vopr Virusol. 1993 Jan-Feb;38(1):18-21.
Using a commercial diagnostic preparation for indirect IFA test, 135 urine samples from 50 patients with HFRS were examined at different periods of the disease. Antibodies were demonstrable in all urine specimens from HFRS patients for 13 days. In 14-20 days they could be detected in half of the patients, and no antibodies could be demonstrated since the 21st day on. The results of urine examination from healthy subjects and some patients with other clinical diagnoses were negative same as controls with normal antigen. The dynamics of antibody titres in the patients' urine differed from that in the blood and was considered as "decreasing" similarly as the clinical disease. The antibody excretion in the urine coincided with the period of renal structure damage and stopped when the normal renal function was restored. The data are discussed from the point of view of the pathogenesis and diagnosis. Special attention was paid to the possibility and advantages of early HFRS diagnosis by antibody determinations in the patients' urine.
使用一种用于间接免疫荧光试验的商业诊断制剂,对50例肾综合征出血热患者的135份尿液样本在疾病的不同时期进行了检测。在肾综合征出血热患者的所有尿液标本中,抗体在13天内均可检测到。在第14 - 20天,半数患者可检测到抗体,自第21天起则无法检测到抗体。健康受试者和一些其他临床诊断患者的尿液检查结果与正常抗原对照一样均为阴性。患者尿液中抗体滴度的动态变化与血液中的不同,且与临床疾病一样被认为是“下降的”。尿液中的抗体排泄与肾结构损伤期一致,当肾功能恢复正常时停止。从发病机制和诊断的角度对这些数据进行了讨论。特别关注了通过检测患者尿液中的抗体进行肾综合征出血热早期诊断的可能性和优势。